Treatment of neovascular ophthalmic disease

Details Treatment of neovascular ophthalmic disease Treatment of neovascular ophthalmic disease

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 31/00 (2006.01) A61K 39/395 (2006.01) A61K 41/00 (2006.01) A61P 27/00 (2006.01) A61K 49/00 (2006.01)

Patent

CA 2466864

Inhibitors of integrin-linked kinase (ILK) are used in the treatment of various eye diseases with underlining pathology of neovascularization of cornea, iris, retina or choroid.

L'invention concerne des inhibiteurs de kinase liée à l'intégrine (ILK) utilisés dans le traitement de différentes maladies de l'oeil comprenant des pathologies sous-jacentes de néovascularisation de la cornée, de l'iris, de la rétine ou de la choroïde.

Affiliated with

Also associated with

Rating

Treatment of neovascular ophthalmic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of neovascular ophthalmic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neovascular ophthalmic disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2016475